This brand name is authorized in Ecuador
The drug SIMAGAL contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Magaldrate
UNII 6V88E24N5T - MAGALDRATE
|
|
Magaldrate is a common antacid drug that is used for the treatment of duodenal and gastric ulcers, esophagitis from gastroesophageal reflux. |
|
2
Simethicone
UNII 92RU3N3Y1O - DIMETHICONE
|
|
Simethicone is a chemically inert, non-systemic gastric defoaming agent that works by altering the elasticity of interfaces of mucus-embedded bubbles in the gastrointestinal tract. The gas bubbles are thus broken down or coalesced and in this form gas is more easily eliminated through eructation or passing flatus. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A02AD02 | Magaldrate | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AD Combinations and complexes of aluminium, calcium and magnesium compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 2551-MEN-1219 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
